Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
Clinical trial NCT04128956 · TERMINATED
Trial details
- NCT number
- NCT04128956
- Sponsor
- University of Zurich
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-11
- Primary completion
- 2024-02-21
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.